These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunization of healthy adults with live attenuated varicella vaccine. Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577 [TBL] [Abstract][Full Text] [Related]
5. Live attenuated varicella vaccine use in immunocompromised children and adults. Gershon AA; Steinberg SP; Gelb L Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495 [TBL] [Abstract][Full Text] [Related]
6. Prospects for use of a varicella vaccine in adults. Hardy IR; Gershon AA Infect Dis Clin North Am; 1990 Mar; 4(1):159-73. PubMed ID: 2155261 [TBL] [Abstract][Full Text] [Related]
11. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. Watson B; Gupta R; Randall T; Starr S J Infect Dis; 1994 Jan; 169(1):197-9. PubMed ID: 8277182 [TBL] [Abstract][Full Text] [Related]
12. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. Hardy I; Gershon AA; Steinberg SP; LaRussa P N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650 [TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of VZV infections in patients with HIV. Gershon AA Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015 [TBL] [Abstract][Full Text] [Related]
14. Current status and prospects of live varicella vaccine. Takahashi M Vaccine; 1992; 10(14):1007-14. PubMed ID: 1335196 [TBL] [Abstract][Full Text] [Related]
15. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. Nader S; Bergen R; Sharp M; Arvin AM J Infect Dis; 1995 Jan; 171(1):13-7. PubMed ID: 7798653 [TBL] [Abstract][Full Text] [Related]
16. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine. Diaz PS; Smith S; Hunter E; Arvin AM J Infect Dis; 1988 Dec; 158(6):1245-52. PubMed ID: 2848901 [TBL] [Abstract][Full Text] [Related]
17. Human immune responses to live attenuated varicella vaccine. Gershon AA Rev Infect Dis; 1991; 13 Suppl 11():S957-9. PubMed ID: 1664134 [TBL] [Abstract][Full Text] [Related]
19. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. Diaz PS; Smith S; Hunter E; Arvin AM J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059 [TBL] [Abstract][Full Text] [Related]
20. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. Gershon AA; Steinberg SP N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]